FGFR2 and neoplasm: In this work, we have shown mechanistically that the abilities of bpAb-B/C and B/D to effectively inhibit ligand-independent FGFR2 fusion activation are likely mediated through enhanced receptor internalization and lysosome-mediated receptor degradation, which results in tumor growth inhibition in vivo.